Local anesthesia in rheumatic patients. Progress and perspectives
Keywords:
rheumatic diseases, therapeutic, local anesthesia, adjuvants of local anesthesia, investigative perspectivesAbstract
Introduction: rheumatic diseases and musculoskeletal diseases are manifested by alterations in the locomotor system, although behind them there may be a disorder of the immune response that leads to the attention of these patients should not focus only on the local aspects, but also in its systemic assessment for the involvement of organs and organ systems such as cardiovascular, respiratory, renal and digestive.
Objective: To review current advances and trends in the use of local anesthesia in patients with rheumatic diseases.
Development: The treatment of these diseases consists mainly of glucocorticoids, non-steroidal anti-inflammatory drugs and disease modifying drugs, in addition to which antirheumatic drugs are increasingly available, although some still require more evidence for its widespread use.
Conclusions: Local anesthesia is one of the therapeutic alternatives that is generally used intra-articularly in rheumatic patients, as well as other medications. In the search for new substances that induce longer periods of analgesia has been intruded into the use of adjuvants or additives, which are drugs that are associated in a synergistic manner with local anesthetics and prolong the duration of sensorimotor block, attenuating the sensation painful and this allows to restrict the required cumulative dose of local anesthetics. Important advances are reported in this regard and perspectives are broadened by the results of the investigations.
Downloads
References
Ministerio de Sanidad, Servicios Sociales e Igualdad. Estrategia en enfermedades reumáticas y músculoesqueléticas del Sistema Nacional de Salud. [Internet]. 2013 Madrid: Centro de publicaciones del Ministerio de Sanidad, Servicios Sociales e igualdad. [citado 2018 Ago 26]. Disponible en: http://publicacionesoficiales.boe.es/
Solis Cartas U, Calvopiña Bejarano SJ. Comorbilidades y calidad de vida en osteoartritis. Rev Cubana de Reumatolo [Internet]. 2018 [citado 2018 Ago 26];20(2). Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/view/609
Buttergeit F, Spies C, Kirwan J. Glucocorticoids. En: Biljsma JWJ editor. EULAR compendium on rheumatic diseases. London, BMJ Publishing Group Ltd., 2009; 601-15.
Gómez A. Nuevos criterios de clasificación de artritis reumatoide. Rheumatol Clin. 2011;6(S3): S33-S37
Gratacós J, et al. Recomendaciones de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en espondiloartritis axial. Reumatol Clin. [Internet]. 2017[citado 2018 Ago 26]; 30(20): 300-14. Disponible en: www.reumatologiaclinica.org
Morales Romero J, González López L, Gámez Nava JI, Vázquez Villegas ML, Castro Enriquez PP. Enfermedades reumáticas y Salud Pública: Artículo de revisión acerca del XXXVIII Congreso Mexicano de Reumatología Revista Altepepaktli: Salud de la comunidad, México, 2010, 6(11):42-45.
Peláez-Ballestas I, Sanin LH, Flores-Camacho R, Navarro-Zarza E, Rivas L, Alvarez-Hernández E, et al. Epidemiología de enfermedades reumáticas en tres comunidades conurbanas de la Ciudad de México: estudio de base comunitaria [resumen]. Reumatol Clin. 2010;6(Supl.1):25-6.
Rodríguez-Amado J, Peláez-Ballestas I, Sanin L, Esquivel-Valerio J, Pérez-Barbosa L, Riega-Torres J, et al. Prevalencia de enfermedades reumáticas. Estudio de base regional [resumen]. Reumatol Clin. 2010;6(Supl.1):27.
Álvarez-Nemegyei J, Angulo-Ramírez AV, Sanin LH, Espinosa-Cuervo G, Goycochea-Robles MV, Cardiel-Ríos MH, et al. Estudio de prevalencia de enfermedades musculoesqueléticas en el estado de Yucatán con la metodología COPCORD [resumen]. Reumatol Clin. 2010;6(Supl.1):82.
Pueyo MJ, Surís X, Larrosa M, Auleda J, Mompart A, Brugulat P, et al. Importancia de los problemas reumáticos en la población de Cataluña: prevalencia y repercusión en la salud percibida, restricción de actividades y utilización de recursos sanitarios. Gac Sanit. 2012;26(1):30-6
Friol J, Carnota O, Rodríguez EM, Campo MF, Porro J. Morbilidad y discapacidad física por osteoartritis en el municipio 10 de Octubre. Rev Cubana Reumatol [Internet]. 2012 [citado 2018 Ago 26];14(19). Disponible en: http://www.revreumatologia.sld.cu/index.php/reumatologia/article/viewArticle/2
Encuesta europea de salud en España [Internet]. Instituto Nacional de Estadística. 2014 [citado 2018 Ago 26]. Disponible en: http://www.ine.es/dyngs/INEbase/es/categoria.htm?c=Estadistica P&cid=1254735573175
Furst DE, Markalanda E, Clements PJ. Immunosuppressives (chlorambucil, cyclosporine, cyclophosphamide, azathioprine, mofetil, tacrolimus. En: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology Textbook, 5th ed. Philadelphia, Elsevier-Mosby, 2011; 529-38.
Seoane-Mato D, et al. Prevalencia de enfermedades reumáticas en población adulta en España (estudio EPISER 2016). Objetivos y metodología. Reumatol Clin. [Internet]. 2017. [citado 2018 Ago 26]. Disponible en: http://dx.doi.org/10.1016/j.reuma.2017.06.009
Sociedad Española de Reumatología. Manual SER de enfermedades reumáticas. 2014. España: Elsevier.
Lisowska B, Rutkowska-Sak L, Maldyk P et al. – Anaesthesiological problems in patients with rheumatoid arthritis undergoing orthopaedic surgeries. Clin Rheumatol, 2008;27:553-556.
Singh SI, Rehou S, Marmai KL, Jones PM. The efficacy of 2 doses of epidural morphine for postcesarean delivery analgesia: a randomized noninferiority trial. Anesth Analg 2013; 117: 677-685.
Tornero J, Sanmartí R, Rodríguez-Valverde V, Martín-Mola E, Marenco JL, González-Alvaro I et al. Actualización del documento de consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en la artritis reumatoide. Reumatol Clin 2010; 6: 23-36.
Sociedad Española de Reumatología. Grupo ESPOGUIA de trabajo de la GPC para el Tratamiento de la Espondiloartritis Axial y la Artritis Psoriásica. Actualización. Sociedad Española de Reumatología, Madrid. 2017.
Courtney P, Doherty M. Joint aspiration and injection and synovial fluid analysis. Best Pract Res Clin Rheumatol 2013; 7: 137-69.
Shipton EA. Nuevas formulaciones de anestésicos locales, parte I. Investigación y práctica de anestesiología; 2012.
Amlan Swain, Deb Sanjay Nag, Seelora Sahu, Devi Prasad Samaddar. Adjuvants to local anesthetics: Current understanding and future trends. World J Clin Cases 2017 August 16; 5(8): 307-323.
Laha A, Ghosh S, Das H. Comparison of caudal analgesia between ropivacaine and ropivacaine with clonidine in children: A randomized controlled trial. Saudi J Anaesth 2012; 6: 197-200.
Eisenach JC, De Kock M, Klimscha W. alpha (2)-adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984-1995). Anesthesiology 1996; 85: 655-674.
Kirksey MA, Haskins SC, Cheng J, Liu SS. Local Anesthetic Peripheral Nerve Block Adjuvants for Prolongation of Analgesia: A Systematic Qualitative Review. PLoS One 2015; 10: e0137312.
Jebaraj B, Khanna P, Baidya DK, Maitra S. Efficacy of epidural local anesthetic and dexamethasone in providing postoperative analgesia: A meta-analysis. Saudi J Anaesth 2016; 10: 322-327.
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
